These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6612746)

  • 1. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
    Mattocks AR; Driver HE
    Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The toxic effects in rats of some synthanecine carbamate and phosphate esters analogous to hepatotoxic pyrrolizidine alkaloids.
    Driver HE; Mattocks AR
    Chem Biol Interact; 1984 Sep; 51(2):201-18. PubMed ID: 6467455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure.
    Culvenor CC; Edgar JA; Jago MV; Qutteridge A; Peterson JE; Smith LW
    Chem Biol Interact; 1976 Mar; 12(3-4):299-324. PubMed ID: 1253333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and toxicity of anacrotine, a pyrrolizidine alkaloid, in rats.
    Mattocks AR; Driver HE
    Chem Biol Interact; 1987; 63(1):91-104. PubMed ID: 3652286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver.
    Mattocks AR; Legg RF; Jukes R
    Toxicol Lett; 1990 Nov; 54(1):93-9. PubMed ID: 2244344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and toxicity of synthetic analogues of macrocyclic diester pyrrolizidine alkaloids.
    Mattocks AR; Driver HE; Barbour RH; Robins DJ
    Chem Biol Interact; 1986 Apr; 58(1):95-108. PubMed ID: 3708724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
    Mattocks AR; Jukes R
    Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
    Mattocks AR; Bird I
    Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
    Mattocks AR; Legg RF
    Chem Biol Interact; 1980 Jun; 30(3):325-36. PubMed ID: 7379211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives.
    Mattocks AR
    Chem Biol Interact; 1981 Jun; 35(3):301-10. PubMed ID: 7226276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic compounds with toxic properties similar to those of pyrrolizidine alkaloids and their pyrrolic metabolites.
    Mattocks AR
    Nature; 1971 Aug; 232(5311):476-7. PubMed ID: 4937207
    [No Abstract]   [Full Text] [Related]  

  • 12. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
    Song Z; He Y; Ma J; Fu PP; Lin G
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues.
    Mattocks AR; Cabral JR
    Cancer Lett; 1982 Oct; 17(1):61-6. PubMed ID: 6817913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH; Johnson K; Carpenter LJ; Roth RA
    J Toxicol Environ Health; 1987; 21(1-2):205-17. PubMed ID: 3573071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of sulphur-bound pyrrolic metabolites in the blood of rats given different types of pyrrolizidine alkaloid.
    Mattocks AR; Jukes R
    Nat Toxins; 1992; 1(2):89-95. PubMed ID: 1344913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.